Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan
· Delayed Price · Currency is TWD 64.20
-0.40 (-0.62%)
At close: Mar 9, 2026
TPE:1720 Revenue
In the year 2025, Standard Chemical & Pharmaceutical had annual revenue of 7.02B TWD with 3.44% growth. Standard Chemical & Pharmaceutical had revenue of 1.79B in the quarter ending December 31, 2025, with 6.71% growth.
Revenue
7.02B
Revenue Growth
+3.44%
P/S Ratio
1.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.02B | 233.80M | 3.44% |
| Dec 31, 2024 | 6.79B | 549.46M | 8.81% |
| Dec 31, 2023 | 6.24B | 388.40M | 6.64% |
| Dec 31, 2022 | 5.85B | 1.25B | 27.09% |
| Dec 31, 2021 | 4.60B | 298.68M | 6.94% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Handa Pharmaceuticals | 1.62B |
| Alar Pharmaceuticals | 1.25M |
| Foresee Pharmaceuticals | 519.61M |
| YungShin Global Holding | 8.37B |
| Synmosa Biopharma | 6.11B |
| ScinoPharm Taiwan | 3.16B |
| Grape King Bio | 10.25B |
| TTY Biopharm Company | 6.50B |